Axovant Sciences Announces Launch of First-in-Class Clinical Programs for Lewy Body Dementia and Reports Financial Results for the Third Fiscal Quarter Ended December 31, 2015

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to Axovant Sciences Announces Launch of First-in-Class Clinical Programs for Lewy Body Dementia and Reports Financial Results for the Third Fiscal Quarter Ended December 31, 2015

Axovant Sciences Ltd. (AXON) Pops Higher

February 11, 2016 11:24 AM EST

Axovant Sciences Ltd. (NYSE: AXON) spiked higher mid-day. Shares up 4%

... More

Axovant Sciences Ltd. (AXON) Reports Q3 Loss Per Share of 64c

February 9, 2016 5:02 PM EST

Axovant Sciences Ltd. (NYSE: AXON) reported Q3 EPS of ($0.64), $0.49 worse than the analyst estimate of ($0.15).

Axovant Sciences also today announced further details of three new clinical trials to address cognitive, behavioral and functional aspects of Lewy body dementia, a disease affecting... More